Acute and chronic effects of ketamine on semantic priming modeling schizophrenia?

Journal of Clinical Psychopharmacology

Volumn 29, Issue 2, 2009, Pages 124-133

  Stefanovic, Ana ^a   Brandner, Brigitta ^b   Klaassen, Elissa ^c   Cregg, Roman ^b   Nagaratnam, Mayavaty ^b   Bromley, Lesley M ^b   Das, Ravi K ^a   Rossell, Susan L ^d   Morgan, Celia J A ^a   Curran, H Valerie ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Glutamate hypofunction; Ketamine; NMDA receptor; Schizophrenia; Semantic priming

Indexed keywords

KETAMINE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG USE; FACILITATION; FEMALE; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; INHIBITION (PSYCHOLOGY); LOW DRUG DOSE; MALE; NORMAL HUMAN; PERCEPTION; PRIORITY JOURNAL; SCHIZOPHRENIA; SEMANTIC MEMORY;

ADOLESCENT; ADULT; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; KETAMINE; MALE; SCHIZOPHRENIC PSYCHOLOGY; SEMANTICS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 67649317013     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31819a4b91     Document Type: Article

References (48)

1. Gouzoulis-Mayfrank E, Voss TA, Morth D, et al. Semantic hyperpriming in thought-disordered patients with schizophrenia: state or trait? A longitudinal investigation. Schizophr Res. 2003;65(2-3):65-73.
2. Rossell SL, Rabe-Hesketh S, Shapleske J, et al. Is semantic fluency differentially impaired in schizophrenic patients with delusions? J Clin Exp Neuropsychol. 1999;21(5):629-642.
3. Sumiyoshi C, Sumiyoshi T, Nohara S, et al. Disorganization of semantic memory underlies alogia in schizophrenia: an analysis of verbal fluency performance in Japanese subjects. Schizophr Res. 2005;74(1):91-100.
4. Minzenberg MJ, Ober BA, Vinogradov S. Semantic priming in schizophrenia: a review and synthesis. J Int Neuropsychol Soc. 2002;8(5):699-720.
5. Pomarol-Clotet E, Oh TM, Laws KR, et al. Semantic priming in schizophrenia: systematic review and meta-analysis. Br J Psychiatry. 2008;192(2):92-97.
6. Rossell SL, Stefanovic A. Semantic priming effects in schizophrenia. Curr Psychiatry Rev. 2007;3:137-145.
7. Newcomer JW, Krystal JH. NMDA receptor regulation of memory and behavior in humans. Hippocampus. 2001;11(5):529-542.
8. Potvin S, Stip E, Roy X Toxic psychoses as pharmacological models of schizophrenia. Curr Psychiatry Rev. 2005;1:23-32.
9. Jentsch JD, Roth RH. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology. 1999;20(3):201-225.
10. Olney JW, Newcomer JW, Farber NB. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res. 1999;33(6):523-533.
11. McCambridge J, Winstock A, Hunt N, et al. 5-year trends in use of hallucinogens and other adjunct drugs among UK dance drug users. Eur Addict Res. 2007;13(1):57-64.
12. Morgan CJA, Rossell SL, Pepper F, et al. Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users. Biol Psychiatry. 2006;59(3):265-272.
13. Rossell SL, David A. Are semantic processing deficits in schizophrenia an access or storage problem? Schizophr Res. 2006;82:121-134.
14. Lambon Ralph MA, Graham KS, Ellis AW, et al. Naming in semantic dementiaVwhat matters? Neuropsychologia. 1998;36(8):775-784.
15. Warrington EK, Cipolotti L. Word comprehension. The distinction between refractory and storage impairments. Brain. 1996;119(Pt 2): 611-625.
16. Becker CA. Semantic context effects in visual word recognition: an analysis of semantic strategies. Mem Cognit. 1980;8(6):493-512.
17. Neely JH, Keefe DE. Semantic context effects on visual word processing: a hybrid prospective-retrospective processing theory. In: Bower GH, ed. The Psychology of Learning and Motivation: Advances in Research and Theory. New York, NY: Academic Press; 1989:207-248.
18. Balota DA, Lorch RF. Depth of automatic spreading activation: mediated priming effects in pronunciation but not in lexical decision. J Exp Psychol Learn Mem Cogn. 1986;12(3):336-345.
19. de Groot AMB. The range of automatic spreading activation in word priming. Journal of Verbal Learning and Verbal Behaviour. 1983;22:417-436.
20. Chwilla DJ, Kolk HHJ, Mulder G. Mediated priming in the lexical decision task: evidence from event-related potentials and reaction time. JMem Lang. 2000;42(3):314-341.
21. McNamara TP, Altarriba J. Depth of spreading activation revisited: semantic mediated priming occurs in lexical decisions. J Mem Lang. 1988;27(5):545-559.
22. Lecardeur L, Giffard B, Laisney M, et al. Semantic hyperpriming in schizophrenic patients: increased facilitation or impaired inhibition in semantic association processing? Schizophr Res. 2007;89(1-3): 243-250.
23. Shafer SL, Varvel JR, Aziz N, et al. Pharmacokinetics of fentanyl administered by computer-controlled infusion pump. Anesthesiology. 1990;73(6):1091-1102.
24. Clements JA, Nimmo WS, Grant IS. Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. J Pharm Sci. 1982;71(5):539-542.
25. Nelson HE. The National Adult Reading Test (NART) Manual. Windsor, United Kingdom: NFER-Nelson; 1982.
26. Lukoff D, Liberman RP, Nuechterlein KH. Manual for the expanded BPRS: symptom monitoring in the rehabilitation of schizophrenic patients. Schizophr Bull. 1986;12(4):578-602.
27. Beck AT, Brown GK, Steer RA. Beck Depression Inventory-II (BDI-II). Manual for Beck Depression Inventory-II. San Antonio, TX: Psychological Corp; 1996.
28. Beck AT, Steer RA. Beck Anxiety Inventory Manual. San Antonio, TX: Psychological Corp; 1990.
29. Mason O, Claridge G, Jackson M. New scales for the assessment of schizotypy. Pers Individ Dif 1995;18(1):7-13.
30. Kucera H, Francis WN. Computational Analysis of Present Day English. Providence, RI: Brown University Press; 1967.
31. Chwilla DJ, Kolk HHJ. Three-step priming in lexical decision. Mem Cognit. 2002;30(2):217-225.
32. Krystal JH, Karper LP, Bennett A, et al. Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans. Psychopharmacology. 1998;135(3):213-229.
33. Mason OJ, Morgan CJA, Stefanovic A, et al. The Psychotomimetic States Inventory (PSI): measuring psychotic-type experiences from ketamine and cannabis. Schizophrenia Research. 2008; 103: 138-142.
34. Bremner JD, Krystal JH, Putnam FW, et al. Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). J Trauma Stress. 1998;11(1): 125-136.
35. Solowij N, Hall W Lee N. Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug. Br J Addict. 1992;87(8):1161-1172.
36. Baddeley A, Emslie H, Nimmo-Smith I. The Spot-the-Word test: a robust estimate of verbal intelligence based on lexical decision. Br J Clin Psychol. 1993;32(Pt 1):55-65.
37. Carlson EB, Putnam FW. An update on the dissociative experiences scale. Dissociation. 1993;6(1):16-27.
38. Krystal JH, Karper LP, Seibyl JP, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 1994;51(3): 199-214.
39. Malhotra AK, Pinals DA, Weingartner H, et al. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology. 1996;14(5):301-307.
40. Kairalla ICJ, Mattos PEL, Hoexter MQ, et al. Attention in schizophrenia and in epileptic psychosis. Braz J Med Biol Res. 2008;41(1):60-67.
41. Butler RW, Braff DL. Delusions: a review and integration. Schizophr Bull. 1991;17(4):633-647.
42. Pomarol-Clotet E, Honey GD, Murray GK, et al. Psychological effects of ketamine in healthy volunteers: phenomenological study. Br J Psychiatry. 2006;189:173-179.
43. Krystal JH, Perry EB, Gueorguieva R, et al. Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. Arch Gen Psychiatry. 2005;62(9):985-995.
44. Block RI, Erwin WJ, Ghoneim MM. Chronic drug use and cognitive impairments. Pharmacol Biochem Behav. 2002;73(3): 491-504.
45. Andreasen NC. Scale for the assessment of thought, language, and communication (TLC). Schizophr Bull. 1986;12(3):473-482.
46. Adler CM, Malhotra AK, Elman I, et al. Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. Am J Psychiatry. 1999;156(10):1646-1649.
47. Morgan CJA, Bedford N, Rossell SL. Evidence of semantic disorganisation using semantic priming in individuals with high schizotypy. Schizophr Res. 2006;84(2-3):272-280.
48. McNamara TP. Semantic Priming: Perspectives From Memory and Word Recognition. New York, NY: Psychology Press; 2005.